Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $311,100 | 206 | 82.3% |
| Travel and Lodging | $55,686 | 198 | 14.7% |
| Food and Beverage | $7,839 | 307 | 2.1% |
| Consulting Fee | $3,150 | 2 | 0.8% |
| Education | $33.36 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $192,060 | 422 | $0 (2020) |
| ABBVIE INC. | $181,441 | 273 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $3,952 | 6 | $0 (2017) |
| Alkermes, Inc. | $150.00 | 1 | $0 (2017) |
| Takeda Pharmaceuticals America, Inc. | $33.00 | 3 | $0 (2017) |
| ABIOMED | $32.01 | 1 | $0 (2017) |
| E.R. Squibb & Sons, L.L.C. | $27.27 | 1 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $19.40 | 1 | $0 (2019) |
| Banner Life Sciences, LLC | $18.72 | 1 | $0 (2022) |
| Lundbeck LLC | $17.86 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $50,331 | 60 | ABBVIE INC. ($50,304) |
| 2023 | $91,068 | 115 | ABBVIE INC. ($91,068) |
| 2022 | $16,484 | 42 | ABBVIE INC. ($16,433) |
| 2021 | $23,636 | 60 | AbbVie Inc. ($23,636) |
| 2020 | $33,184 | 73 | Allergan, Inc. ($33,184) |
| 2019 | $68,661 | 154 | Allergan Inc. ($68,631) |
| 2018 | $33,710 | 80 | Allergan Inc. ($33,710) |
| 2017 | $60,734 | 131 | Allergan Inc. ($56,535) |
All Payment Transactions
715 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.87 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,250.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $30.25 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Travel and Lodging | In-kind items and services | $3.35 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,250.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,250.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Travel and Lodging | In-kind items and services | $541.87 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Education | In-kind items and services | $27.27 | General |
| Category: Psychiatry/Psychology | ||||||
| 09/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Travel and Lodging | In-kind items and services | $386.99 | General |
| Category: NEUROSCIENCE | ||||||
| 09/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,250.00 | General |
| Category: NEUROSCIENCE | ||||||
| 09/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,250.00 | General |
| Category: NEUROSCIENCE | ||||||
| 09/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Travel and Lodging | In-kind items and services | $705.00 | General |
| Category: NEUROSCIENCE | ||||||
| 09/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: NEUROSCIENCE | ||||||
| 08/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.28 | General |
| Category: NEUROSCIENCE | ||||||
| 08/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: NEUROSCIENCE | ||||||
| 08/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Travel and Lodging | In-kind items and services | $3.35 | General |
| Category: NEUROSCIENCE | ||||||
| 07/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: NEUROSCIENCE | ||||||
| 07/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,150.00 | General |
| Category: NEUROSCIENCE | ||||||
| 07/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,250.00 | General |
| Category: NEUROSCIENCE | ||||||
| 06/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Travel and Lodging | In-kind items and services | $1,370.55 | General |
| Category: NEUROSCIENCE | ||||||
| 06/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Travel and Lodging | In-kind items and services | $226.36 | General |
| Category: NEUROSCIENCE | ||||||
| 06/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $68.25 | General |
| Category: NEUROSCIENCE | ||||||
| 06/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: NEUROSCIENCE | ||||||
| 05/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 192 | 1,097 | $159,300 | $57,114 |
| 2022 | 7 | 265 | 1,447 | $208,625 | $75,966 |
| 2021 | 5 | 267 | 1,747 | $252,325 | $94,565 |
| 2020 | 6 | 283 | 1,890 | $277,100 | $91,325 |
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 61 | 436 | $65,400 | $25,255 | 38.6% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 58 | 481 | $72,150 | $23,291 | 32.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 22 | 82 | $6,150 | $3,163 | 51.4% |
| 90832 | Psychotherapy, 30 minutes | Office | 2023 | 37 | 62 | $9,300 | $3,122 | 33.6% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2023 | 14 | 36 | $6,300 | $2,284 | 36.2% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 74 | 645 | $96,750 | $31,818 | 32.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 75 | 530 | $79,500 | $30,557 | 38.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 34 | 138 | $10,350 | $5,397 | 52.1% |
| 90832 | Psychotherapy, 30 minutes | Office | 2022 | 39 | 55 | $8,250 | $3,254 | 39.4% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2022 | 19 | 45 | $7,875 | $2,969 | 37.7% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 12 | 12 | $4,800 | $1,619 | 33.7% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 12 | 22 | $1,100 | $351.28 | 31.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 84 | 702 | $105,300 | $42,255 | 40.1% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 84 | 804 | $120,600 | $40,995 | 34.0% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 41 | 143 | $10,725 | $5,372 | 50.1% |
| 90832 | Psychotherapy, 30 minutes | Office | 2021 | 44 | 58 | $8,700 | $3,390 | 39.0% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2021 | 14 | 40 | $7,000 | $2,552 | 36.5% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 102 | 883 | $132,450 | $44,695 | 33.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 102 | 809 | $121,350 | $38,424 | 31.7% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 38 | 112 | $8,400 | $3,533 | 42.1% |
| 90836 | Psychotherapy, 45 minutes | Office | 2020 | 17 | 54 | $9,450 | $3,463 | 36.6% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 11 | 11 | $4,400 | $930.93 | 21.2% |
| 99211 | Established patient office or other outpatient visit, typically 5 minutes | Office | 2020 | 13 | 21 | $1,050 | $279.10 | 26.6% |
About Dr. Anil Parikh, MD
Dr. Anil Parikh, MD is a Psychiatry healthcare provider based in Fairlawn, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1437218922.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anil Parikh, MD has received a total of $377,808 in payments from pharmaceutical and medical device companies, with $50,331 received in 2024. These payments were reported across 715 transactions from 14 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($311,100).
As a Medicare-enrolled provider, Parikh has provided services to 1,007 Medicare beneficiaries, totaling 6,181 services with total Medicare billing of $318,970. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Fairlawn, OH
- Active Since 12/08/2006
- Last Updated 07/08/2007
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1437218922
Products in Payments
- VRAYLAR (Drug) $373,225
- AUSTEDO (Drug) $3,389
- SD809-TD (Drug) $562.95
- VIIBRYD (Drug) $276.01
- Trintellix (Drug) $52.40
- Impella (Device) $32.01
- COBENFY (Drug) $27.27
- BAFIERTAM (Drug) $18.72
- REXULTI (Drug) $17.86
- LATUDA (Drug) $16.52
- INGREZZA (Drug) $14.80
- CAPLYTA (Drug) $14.41
- NEUROSTAR TMS THERAPY (Device) $10.63
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Fairlawn
Anand Chaturvedi, M.d, M.D
Psychiatry — Payments: $135,481
Bharat Shah, M.d, M.D
Psychiatry — Payments: $780.59
Zachary Rosenberg
Psychiatry — Payments: $34.46
Maher Mansour, M.d, M.D
Psychiatry — Payments: $26.38
Mrs. Dora Norton, Md, MD
Psychiatry
Dr. Jodie Skillicorn, D.o, D.O
Psychiatry